Announcements

Stephen Feider, Chief Financial Officer of Beta Bionics, Inc. (NASDAQ:BBNX), filed a Form 4 on November 9, 2026, disclosing a same-day option exercise and sale of 382 shares of common stock on November 5, 2026, pursuant to a Rule 10b5-1 plan.

Scott H. Keeney, an officer and director of nLight, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 200,000 shares of nLight common stock through Fidelity Brokerage Services LLC on NASDAQ.

Beta Bionics, Inc. officer Stephen Feider filed a Form 144 notice of proposed sale of 744 shares of common stock, with an approximate sale date of November 9, 2026, through Merrill Lynch.

Charles S. Coleman, an officer of OPENLANE, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 1,207 shares of common stock acquired through a stock option exercise on the same date.

Ankit B. Patadia, EVP and Treasurer of Healthpeak Properties, Inc., filed a Form 4 on November 9, 2026, disclosing the sale of 6,115 shares of common stock on that same date.

A Form 144 notice of proposed sale was filed on November 9, 2026, disclosing that the Lori R Schwartz 2025 Gift Trust U/A DTD 03/28/2025 intends to sell 55,555 shares of common stock in Rush Street Interactive, Inc. (NYSE:RSI).

Ankit B. Patadia, an officer of Healthpeak Properties, Inc., filed a Form 144 notice on November 9, 2026, disclosing a proposed sale of 6,115 shares of common stock on the New York Stock Exchange.